Yorktown Management & Research CO Inc Crispr Therapeutics Ag Transaction History

Yorktown Management & Research CO Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 29, 2022	SELL	$53.19 - $79.24 $255,312 - $380,352	-4,800 Closed	0 $0
Q2 2021 Aug 03, 2021	SELL	$100.84 - $161.89 $363,024 - $582,804	-3,600 Reduced 42.86%	4,800 $777,000
Q1 2021 May 11, 2021	SELL	$110.72 - $210.04 $22,144 - $42,008	-200 Reduced 2.33%	8,400 $1.02 Million
Q3 2020 Nov 06, 2020	BUY	$78.5 - $100.64 $109,900 - $140,896	1,400 Added 19.44%	8,600 $719,000
Q2 2020 Aug 11, 2020	BUY	$38.5 - $76.05 $277,200 - $547,560	7,200 New	7,200 $529,000

543

67.4M

3.5M

3.08M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $4.32B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Yorktown Management & Research CO Inc, based on Form 13F filings with the SEC.

Stay updated on Yorktown Management & Research CO Inc with notifications on news.